Search Results
MDL-29951 2 mg | 99.07%
TargetMol
GNE-7915 5 mg | Purity Not Available
TargetMol
GNE-7915 is a highly potent, selective and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor.
More Information Supplier PageGNE-7915 25 mg | Purity Not Available
TargetMol
GNE-7915 is a highly potent, selective and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor.
More Information Supplier PageISX-9 25 mg | 98.26%
TargetMol
ISX9 is necessary to activate neuron-specific genes as neurogenesis inducer.
More Information Supplier PageISX-9 2 mg | 98.26%
TargetMol
ISX9 is necessary to activate neuron-specific genes as neurogenesis inducer.
More Information Supplier PageJ-147 100 mg | 99.61%
TargetMol
J-147 is an experimental drug with reported effects against both Alzheimer’s disease and ageing in mouse models of accelerated aging. It is a curcumin derivative and a potent neurogenic and neuroprotective drug candidate initially developed for the treatment of neurodegenerative conditions associated with aging that impacts many pathways implicated in the pathogenesis of diabetic neuropathy.
More Information Supplier PageGW627368 2 mg | 99.54%
TargetMol
GW627368X is a novel, potent and selective antagonist of prostanoid EP4 receptor.
More Information Supplier PagePFI-4 25 mg | Purity Not Available
TargetMol
PFI-4 is a potent and selective and cell-permeable BRPF1 bromodomain inhibitor.
More Information Supplier PageGNE-7915 200 mg | Purity Not Available
TargetMol
GNE-7915 is a highly potent, selective and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor.
More Information Supplier Page
